Edwin A Takahashi1, David F Kallmes1, Chad J Fleming2, Robert J McDonald1, Michael A McKusick2, Haraldur Bjarnason2, William S Harmsen3, Sanjay Misra4. 1. Department of Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. 2. Department of Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905; Division of Vascular and Interventional Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. 3. Department of Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905; Department of Clinical Statistics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. 4. Department of Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905; Division of Vascular and Interventional Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. Electronic address: misra.sanjay@mayo.edu.
Abstract
PURPOSE: To determine incidence, predictors, and clinical outcomes of postcontrast acute kidney injury (PC-AKI) following renal artery stent placement for atherosclerotic renal artery stenosis. MATERIALS AND METHODS: This retrospective study reviewed 1,052 patients who underwent renal artery stent placement for atherosclerotic renal artery stenosis; 437 patients with follow-up data were included. Mean age was 73.6 years ± 8.3. PC-AKI was defined as absolute serum creatinine increase ≥ 0.3 mg/dL or percentage increase in serum creatinine ≥ 50% within 48 hours of intervention. Logistic regression analysis was performed to identify risk factors for PC-AKI. The cumulative proportion of patients who died or went on to hemodialysis was determined using Kaplan-Meier survival analysis. RESULTS: Mean follow-up was 71.1 months ± 68.4. PC-AKI developed in 26 patients (5.9%). Patients with PC-AKI had significantly higher levels of baseline proteinuria compared with patients without PC-AKI (odds ratio = 1.38; 95% confidence interval, 1.11-1.72; P = .004). Hydration before intervention, chronic kidney disease stage, baseline glomerular filtration rate, statin medications, contrast volume, and iodine load were not associated with higher rates of PC-AKI. Dialysis-free survival and mortality rates were not significantly different between patients with and without PC-AKI (P = .50 and P = .17, respectively). CONCLUSIONS: Elevated baseline proteinuria was the only predictor for PC-AKI in patients undergoing renal artery stent placement. Patients who developed PC-AKI were not at greater risk for hemodialysis or death.
PURPOSE: To determine incidence, predictors, and clinical outcomes of postcontrast acute kidney injury (PC-AKI) following renal artery stent placement for atherosclerotic renal artery stenosis. MATERIALS AND METHODS: This retrospective study reviewed 1,052 patients who underwent renal artery stent placement for atherosclerotic renal artery stenosis; 437 patients with follow-up data were included. Mean age was 73.6 years ± 8.3. PC-AKI was defined as absolute serum creatinine increase ≥ 0.3 mg/dL or percentage increase in serum creatinine ≥ 50% within 48 hours of intervention. Logistic regression analysis was performed to identify risk factors for PC-AKI. The cumulative proportion of patients who died or went on to hemodialysis was determined using Kaplan-Meier survival analysis. RESULTS: Mean follow-up was 71.1 months ± 68.4. PC-AKI developed in 26 patients (5.9%). Patients with PC-AKI had significantly higher levels of baseline proteinuria compared with patients without PC-AKI (odds ratio = 1.38; 95% confidence interval, 1.11-1.72; P = .004). Hydration before intervention, chronic kidney disease stage, baseline glomerular filtration rate, statin medications, contrast volume, and iodine load were not associated with higher rates of PC-AKI. Dialysis-free survival and mortality rates were not significantly different between patients with and without PC-AKI (P = .50 and P = .17, respectively). CONCLUSIONS: Elevated baseline proteinuria was the only predictor for PC-AKI in patients undergoing renal artery stent placement. Patients who developed PC-AKI were not at greater risk for hemodialysis or death.
Authors: Sjoerd Jens; Sanne M Schreuder; Diederik W De Boo; Lukas C van Dijk; Hans van Overhagen; Shandra Bipat; Mark J W Koelemay; Jim A Reekers Journal: Eur Radiol Date: 2015-12-02 Impact factor: 5.315
Authors: David M Safley; Adam C Salisbury; Thomas T Tsai; Eric A Secemsky; Kevin F Kennedy; R Kevin Rogers; Faisal Latif; Nicolas W Shammas; Lawrence Garcia; Matthew A Cavender; Kenneth Rosenfield; Anand Prasad; John A Spertus Journal: JACC Cardiovasc Interv Date: 2021-02-08 Impact factor: 11.195
Authors: Edwin A Takahashi; David F Kallmes; Kristin C Mara; William S Harmsen; Sanjay Misra Journal: Diagn Interv Radiol Date: 2018-11 Impact factor: 2.630
Authors: Michael C Jundt; Edwin A Takahashi; William S Harmsen; Sanjay Misra Journal: Cardiovasc Intervent Radiol Date: 2019-07-02 Impact factor: 2.740
Authors: Ralph Weber; Robert van Hal; Paul Stracke; Jeffrie Hadisurya; Hannes Nordmeyer; René Chapot Journal: J Am Heart Assoc Date: 2020-02-13 Impact factor: 5.501